Catalyst Pharmaceuticals (CPRX) Other Accumulated Expenses (2011 - 2026)

Catalyst Pharmaceuticals has reported Other Accumulated Expenses for 11 years, with the latest figure at $745000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 66.52% year-over-year to $745000.0; the trailing twelve-month figure through Mar 2026 stood at $745000.0 (down 66.52% YoY), and the FY2025 full-year result was $840000.0, up 101.44% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $745000.0, down from $840000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $2.2 million in Q1 2025, with the low at $372000.0 in Q2 2024.
• Historically, Other Accumulated Expenses has averaged $789111.1 across 4 years, with a median of $745000.0 in 2026.
• Annual changes were most pronounced in 2025 — Other Accumulated Expenses soared 101.44% — and 2026, when it slumped 66.52%.
• Catalyst Pharmaceuticals' Other Accumulated Expenses stood at $465000.0 in 2023, then dropped by 10.32% to $417000.0 in 2024, then soared by 101.44% to $840000.0 in 2025, then slipped by 11.31% to $745000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $745000.0 (Q1 2026), $840000.0 (Q4 2025), and $842000.0 (Q3 2025), per Business Quant data.